Co-Diagnostics, Inc. Depreciation and Amortization
Co-Diagnostics, Inc. (CODX) reported Depreciation and Amortization of $839.24 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2025-11-13
- Co-Diagnostics, Inc. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $267.38K, a 23.87% decline year-over-year.
- Co-Diagnostics, Inc. depreciation, depletion and amortization for the quarter ending 2025-06-30 was $291.41K, a 13.87% decline year-over-year.
- Co-Diagnostics, Inc. depreciation, depletion and amortization for the quarter ending 2025-03-31 was $280.44K, a 15.16% decline year-over-year.
- Co-Diagnostics, Inc. depreciation, depletion and amortization for the quarter ending 2024-12-31 was $357.12K, a 14.14% increase year-over-year.
- Co-Diagnostics, Inc. depreciation, depletion and amortization for fiscal 2024 was $1.38M, a 11.93% increase from fiscal 2023.
- Co-Diagnostics, Inc. depreciation, depletion and amortization for fiscal 2023 was $1.23M, a 4.07% decline from fiscal 2022.
- Co-Diagnostics, Inc. depreciation, depletion and amortization for fiscal 2022 was $1.28M, a 282.49% increase from fiscal 2021.
- Co-Diagnostics, Inc. depreciation, depletion and amortization for fiscal 2021 was $335.36K, a 141.90% increase from fiscal 2020.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 6 month as first filed | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $267.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $558.80K derived: sum of 2 quarters · filed 2025-11-13 | $839.24K 10-Q · filed 2025-11-13 | $1.20M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2025-06-30 | $291.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $571.86K 10-Q · filed 2025-08-14 | $928.98K derived: sum of 3 quarters · filed 2025-08-14 | $1.28M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2025-03-31 | $280.44K 10-Q · filed 2025-05-08 | $637.57K derived: sum of 2 quarters · filed 2025-05-08 | $988.80K derived: sum of 3 quarters · filed 2025-11-13 | $1.33M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-12-31 | $357.12K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $708.36K derived: sum of 2 quarters · filed 2025-11-13 | $1.05M derived: sum of 3 quarters · filed 2025-11-13 | $1.38M 10-K · filed 2025-03-27 | |
| 2024-09-30 | $351.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $689.57K derived: sum of 2 quarters · filed 2025-11-13 | $1.02M 10-Q · filed 2025-11-13 | $1.33M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $338.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $668.91K 10-Q · filed 2025-08-14 | $981.79K derived: sum of 3 quarters · filed 2025-08-14 | $1.28M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $330.57K 10-Q · filed 2025-05-08 | $643.45K derived: sum of 2 quarters · filed 2025-05-08 | $939.79K derived: sum of 3 quarters · filed 2025-05-08 | $1.25M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $312.88K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $609.22K derived: sum of 2 quarters · filed 2025-03-27 | $914.46K derived: sum of 3 quarters · filed 2025-03-27 | $1.23M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $296.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $601.59K derived: sum of 2 quarters · filed 2024-11-07 | $917.60K 10-Q · filed 2024-11-07 | $1.22M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $305.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $621.26K 10-Q · filed 2024-08-08 | $919.87K derived: sum of 3 quarters · filed 2024-08-08 | $1.23M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $316.01K 10-Q · filed 2024-05-09 | $614.63K derived: sum of 2 quarters · filed 2024-05-09 | $927.12K derived: sum of 3 quarters · filed 2024-05-09 | $1.35M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $298.62K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $611.11K derived: sum of 2 quarters · filed 2024-03-14 | $1.04M derived: sum of 3 quarters · filed 2024-03-14 | $1.28M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $312.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $736.84K derived: sum of 2 quarters · filed 2023-11-09 | $984.10K 10-Q · filed 2023-11-09 | $1.09M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $424.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $671.61K 10-Q · filed 2023-08-10 | $671.11K 10-Q · filed 2022-08-11 | $774.21K derived: sum of 3 quarters · filed 2023-08-10 | $868.25K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $247.26K 10-Q · filed 2023-05-11 | $349.87K derived: sum of 2 quarters · filed 2023-05-11 | $443.91K derived: sum of 3 quarters · filed 2023-05-11 | $515.62K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $102.61K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $196.64K derived: sum of 2 quarters · filed 2023-03-16 | $268.36K derived: sum of 3 quarters · filed 2023-03-16 | $335.36K 10-K · filed 2023-03-16 | |
| 2021-09-30 | $94.04K 10-Q · filed 2021-11-12 | $165.75K derived: sum of 2 quarters · filed 2021-11-12 | $232.76K 10-Q · filed 2022-11-10 | $289.94K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-06-30 | $71.71K 10-Q · filed 2021-08-12 | $138.72K 10-Q · filed 2022-08-11 | $195.90K derived: sum of 3 quarters · filed 2022-05-12 | $231.39K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-03-31 | $67.00K 10-Q · filed 2022-05-12 | $124.18K derived: sum of 2 quarters · filed 2022-05-12 | $159.67K derived: sum of 3 quarters · filed 2022-05-12 | $184.89K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $57.18K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $92.67K derived: sum of 2 quarters · filed 2022-03-24 | $117.89K derived: sum of 3 quarters · filed 2022-03-24 | $138.63K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $35.49K 10-Q · filed 2021-11-12 | $60.71K derived: sum of 2 quarters · filed 2021-11-12 | $81.46K 10-Q · filed 2021-11-12 | $100.59K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $25.22K 10-Q · filed 2021-08-12 | $45.97K 10-Q · filed 2021-08-12 | $65.10K derived: sum of 3 quarters · filed 2021-08-12 | $82.11K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $20.75K 10-Q · filed 2021-05-13 | $39.88K derived: sum of 2 quarters · filed 2021-05-13 | $56.89K derived: sum of 3 quarters · filed 2021-05-13 | $72.98K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $19.13K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $36.14K derived: sum of 2 quarters · filed 2021-03-25 | $52.23K derived: sum of 3 quarters · filed 2021-03-25 | $65.90K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $17.01K 10-Q · filed 2020-11-16 | $33.10K derived: sum of 2 quarters · filed 2020-11-16 | $46.77K 10-Q · filed 2020-11-16 | $59.90K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | $16.09K 10-Q/A · filed 2020-11-03 | $29.76K 10-Q/A · filed 2020-11-03 | $42.89K derived: sum of 3 quarters · filed 2020-11-03 | $55.51K derived: sum of 4 quarters · filed 2020-11-03 | |
| 2019-03-31 | $13.67K 10-Q · filed 2020-05-14 | $26.80K derived: sum of 2 quarters · filed 2020-05-14 | $39.41K derived: sum of 3 quarters · filed 2020-05-14 | $52.03K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $13.13K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $25.75K derived: sum of 2 quarters · filed 2020-03-30 | $38.36K derived: sum of 3 quarters · filed 2020-03-30 | $50.77K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $12.62K 10-Q · filed 2019-11-12 | $25.23K derived: sum of 2 quarters · filed 2019-11-12 | $37.63K 10-Q · filed 2019-11-12 | $50.16K derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $12.62K 10-Q · filed 2019-08-14 | $25.02K 10-Q · filed 2019-08-14 | $37.55K derived: sum of 3 quarters · filed 2019-08-14 | $49.96K derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $12.40K 10-Q · filed 2019-05-14 | $24.93K derived: sum of 2 quarters · filed 2019-05-14 | $37.35K derived: sum of 3 quarters · filed 2019-05-14 | $48.44K derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | $12.53K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $24.95K derived: sum of 2 quarters · filed 2019-04-01 | $36.03K derived: sum of 3 quarters · filed 2019-04-01 | $45.76K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $12.42K 10-Q · filed 2018-11-14 | $23.50K derived: sum of 2 quarters · filed 2018-11-14 | $33.23K 10-Q · filed 2018-11-14 | $41.25K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $11.09K 10-Q · filed 2018-08-10 | $20.81K 10-Q · filed 2018-08-10 | $28.84K derived: sum of 3 quarters · filed 2018-08-10 | $36.13K derived: sum of 4 quarters · filed 2018-08-10 | |
| 2017-03-31 | $9.73K 10-Q · filed 2018-05-14 | $17.75K derived: sum of 2 quarters · filed 2018-05-14 | $25.05K derived: sum of 3 quarters · filed 2018-05-14 | $33.91K derived: sum of 4 quarters · filed 2018-05-14 | |
| 2016-12-31 | $8.03K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $15.32K derived: sum of 2 quarters · filed 2018-03-28 | $24.18K derived: sum of 3 quarters · filed 2018-03-28 | $37.49K 10-K · filed 2018-03-28 | |
| 2016-09-30 | $7.29K 10-Q · filed 2017-11-14 | $16.16K derived: sum of 2 quarters · filed 2017-11-14 | $29.47K 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $8.86K 10-Q · filed 2017-08-25 | $22.17K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |